Agenus Inc.

AGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $60.2M $71.4M $136.7M $25.7M $27.4M $21.5M $10.7M $19.8M
Accounts Receivable $1.1M $11.4M $9.8M $463.0K $1.2K $552.3K $0 $35.0K
Inventory $79.5K $88.2K $88.2K $95.7K $0 $16.0K $20.1K $26.4K
Total Current Assets $73.6M $91.3M $184.1M $42.7M $28.2M $22.6M $12.0M $20.9M
Property, Plant & Equipment $26.2M $25.6M $15.3M $6.0M $2.8M $2.6M $4.1M $6.2M
Goodwill $23.0M $22.4M $22.8M $17.9M $2.6M $2.6M $2.6M $2.6M
Intangible Assets (Excl. Goodwill) $14.4M $16.4M $18.8M $6.8M $0 — — —
Total Assets $138.4M $157.0M $242.2M $74.5M $34.8M $29.1M $19.8M $30.9M
Liabilities
Accounts Payable $8.1M $5.4M $4.5M $1.7M $834.7K $634.8K $807.9K $698.6K
Total Current Liabilities $56.4M $40.9M $28.9M $9.2M $10.3M $4.8M $4.8M $5.4M
Long-Term Debt $142.4M $130.5M $114.3M $4.8M — — — —
Total Liabilities $214.2M $196.1M $171.5M $51.5M $39.3M $46.7M $40.6M $45.6M
Stockholders' Equity
Retained Earnings $-1.03B $-905.3M $-779.2M $-691.3M $-649.1M $-619.0M $-607.7M $-584.4M
Total Stockholders' Equity $-75.8M $-39.1M $70.7M $23.0M $-4.5M $-17.6M $-20.8M $-14.7M
← Newer Page 2 of 2 Older →